UK Health Security Agency released its weekly report on the COVID-19 vaccine in England from November 18, 2021 (week 46). Dates were divided into 10 age groups. From the age of 50 onwards, there were more people who died of COVID-19 from people who received the full vaccine than those who did not.
On page 21 of this report, it shows the death of COVID-19 (a) within 28 days and (b) within 60 days of positive samples or with COVID-19 stated on the death certificate, with vaccination between 42 weeks and 45 weeks. of 2021.
The above data show that at the age of 50, most people die within 28 days of the COVID-19 test and were reported to have taken a second dose of COVID-19 vaccine no later than 14 days before the sample date. Between the ages of 50 and 80+ who received full immunization, 2,823 deaths were reported compared to 587 deaths who were not vaccinated. Most of the dead are in the 80+ unsafe age group.
The above data show that at the age of 50, most people die within 60 days of testing COVID-19 and were reported to have taken a second dose of COVID-19 vaccine within 14 days before the sample date. Between the ages of 50 and 80+ who received full immunizations, 3,347 deaths were reported compared to 675 deaths who did not follow up. Most of the dead are in the 80+ unsafe age group.
The table below shows the incidence of COVID-19 infections, hospitalization, and mortality of both vaccinated and non-vaccinated people.
This is how they interpret their data based on reports:
These data should be considered based on the status of the vaccine in the population groups shown throughout the report. In the case of high prevalence of human immunization, even with the most effective vaccines, it is expected that a greater number of cases, hospitalizations and deaths will occur in vaccinated individuals, because a greater number of people are vaccinated than those without vaccines. and no vaccine works 100%. This is especially true because the vaccine has been given priority over people who are at high risk for serious infections. Individuals in high-risk groups may also be at risk of hospitalization or death due to lack of COVID-19, so they may be hospitalized or die of COVID-19 rather than COVID-19.
In case of vaccination cases, bedridden patients should not be used to evaluate the effectiveness of the vaccine because of differences in risk, behavior and testing of people who are vaccinated and those who are not vaccinated. The standards of people who are vaccinated and those who are not vaccinated are rude and do not consider the stigma contained in the data. There may be systemic differences between vaccinated and non-vaccinated individuals, for example:
- people with adequate immunizations are more likely to take care of their health and thus have a chance to get tested for COVID-19 and have a better chance of being diagnosed (based on the NHS Test and Trace)
- many of those who have been in line for vaccination are at high risk of COVID-19 because of their age, occupation, family or health problems.
- people with complete immunizations and those who have not been vaccinated may react differently, especially when it comes to social media which is why they may have different forms of COVID-19.
- people who have not been vaccinated are more likely to be exposed to COVID-19 weeks or months before the trial period described in this report. This gives them natural protection against the virus for several months which may have led to a decline in the number of people in recent weeks.
This bias is most evident when more people are vaccinated and the differences between those who are vaccinated and those who are not vaccinated are very different in ways that are not calculated without a valid vaccine trial. The effectiveness of the vaccine is compared from different regions and is described on pages 5 to 8 of this report.
The Gateway Pundit recently reported that a legitimate European Union official website suspected of drug abuse is reporting 30,551 people have died and 1,163,356 adverse drug reactions from COVID Pfizer, Moderna, Johnson & Johnson, and AstraZeneca vaccine until November 13, 2021 depending on the submission of its order.